Showing results (1411-1420 of 1,882) with videos related to

Sort By:
Pageof 189
European Journal of Clinical Pharmacology|May 31, 2012
Epidemiology and potential associated risk factors of drug-related problems in hospitalised children in the United Kingdom and Saudi ArabiaAsia N Rashed, Antje Neubert, Stephen Tomlin, et al.
The Journal of Urology|February 22, 2008
Safety and efficacy of flexible ureterorenoscopy and holmium:YAG lithotripsy for intrarenal stones in anticoagulated casesBurak Turna, Robert J Stein, Marc C Smaldone, et al.
Transplantation Direct|July 20, 2019
Potential of Membranes Surrounding the Fetus as Immunoprotective Cell-Carriers for Allogeneic TransplantationsPadma Priya Togarrati, Nuntana Dinglasan, Elizabeth Yee, et al.
Neurogastroenterology and Motility|April 10, 2023
Optimizing nutrition IN pediatric intestinal pseudo-obstruction syndromeMatilde Pescarin, Hannah Day, Nikhil Thapar, et al.
Lupus Science & Medicine|October 12, 2018
Increased alloreactive and autoreactive antihuman leucocyte antigen antibodies associated with systemic lupus erythematosus and rheumatoid arthritisRachael P Jackman, Giovanna I Cruz, Joanne Nititham, et al.
Science (New York, N.Y.)|July 19, 1996
Cytoplasmic tail-dependent localization of CD1b antigen-presenting molecules to MIICsM Sugita, R M Jackman, E van Donselaar, et al.
Vaccine|June 14, 2005
Evaluation of AD472, a live attenuated recombinant herpes simplex virus type 2 vaccine in guinea pigsMark N Prichard, Ravi Kaiwar, Winthrop T Jackman, et al.
Journal of Cardiovascular Electrophysiology|April 1, 2008
Anatomy and physiology of the right interganglionic nerve: implications for the pathophysiology of inappropriate sinus tachycardiaJing Zhou, Benjamin J Scherlag, Guodong Niu, et al.
Biochemical Pharmacology|October 24, 1991
The biochemical pharmacology of the thymidylate synthase inhibitor, 2-desamino-2-methyl-N10-propargyl-5,8-dideazafolic acid (ICI 198583)A L Jackman, D R Newell, W Gibson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2008
Autocrine production of amphiregulin predicts sensitivity to both gefitinib and cetuximab in EGFR wild-type cancersKimio Yonesaka, Kreshnik Zejnullahu, Neal Lindeman, et al.
Pageof 189